Dr. Minrong Ai is a research scientist in the Division of Diabetes and Complications, Lilly Research Laboratories. Minrong Ai earned his Ph.D. degree in Case Western Reserve University in 2006. Minrong Ai conducted his first postdoctoral research in Washington University to investigate molecular mechanisms of glutamatergic synapse formation. Minrong Ai finished his second postdoctoral research in New York University, where he mapped neural circuits underlying innate behaviors. At Lilly Research Laboratories, he is now investigating the effects of anti-diabetes and anti-obesity drugs on central nervous system. | Minrong Ai | Principle Research Scientist, Diabetes and Complications, Eli Lilly & Companies